58 Results

People

  1. Danishefsky
    Danishefsky
  2. Li
    Li
  3. Norton
    Norton
  4. Rampal
    Rampal
  5. Wu
    Wu
  6. Morris
    Morris
  7. Sawyers
    Sawyers
  8. Stockdill
    Stockdill
  9. Abida
    Abida
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (33)
  2. Solid Tumor Oncology Division (22)
  3. Sloan Kettering Institute Faculty (13)
  4. Hematologic Malignancies, Division of (12)
  5. Molecular Pharmacology and Chemistry Program Faculty (12)
  6. Center for Hematologic Malignancies (11)
  7. Breast Medicine Service (10)
  8. Genitourinary Oncology Service (9)
  9. Survivorship Research (8)
  10. GSK Faculty (7)
  1. "nitriles"
Formats
  1. Journal Article (55)
  2. Review (3)
Groups
  1. Department of Medicine (33)
  2. Solid Tumor Oncology Division (22)
  3. Sloan Kettering Institute Faculty (13)
  4. Hematologic Malignancies, Division of (12)
  5. Molecular Pharmacology and Chemistry Program Faculty (12)
  6. Center for Hematologic Malignancies (11)

More Groups

People
  1. Samuel Danishefsky (11)
  2. Xuechen Li (7)
  3. Larry Norton (4)
  4. Raajit Rampal (4)
  5. Xiangyang Wu (4)
  6. Charles Sawyers (3)

More People

Years
  1. 2025 (4)
  2. 2024 (8)
  3. 2023 (2)
  4. 2022 (6)
  5. 2021 (1)
  6. 2017 (1)

More Years

Publications
  1. Journal of the American Chemical Society (8)
  2. Clinical Cancer Research (4)
  3. Cancer Research (3)
  4. Journal of Clinical Oncology (3)
  5. Breast Cancer Research and Treatment (2)
  6. Cancer (2)

More Publications

Publishers
  1. American Chemical Society (9)
  2. Nature Publishing Group (9)
  3. American Association for Cancer Research (7)
  4. Elsevier Inc. (4)
  5. American Society of Clinical Oncology (3)
  6. Springer (3)

More Publishers

Results (58)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimization of allogeneic hematopoietic cell transplantation for patients with myelofibrosis treated with ruxolitinib: Eligibility, best practices, and improving transplant outcomes
    Review

    Wall, S. A.; Tamari, R.; DeFilipp, Z.; Hobbs, G. S.
    Annals of Hematology (2025)

    Fulltext@MSK | Save
  • Emerin dysregulation drives the very-small-nuclear phenotype and lineage plasticity that associate with a clinically aggressive subtype of prostate cancer
    Journal Article

    Zhang, L.; Teng, P. C.; Cavassani, K. A.; Wang, J.; Grasso, C.; Watson, J.; Chen, Z.; Tu, K. H.; Salumbides, B.; Rohena-Rivera, K.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Pacritinib response is associated with overall survival in myelofibrosis: PERSIST-2 landmark analysis of survival
    Journal Article

    Ajufo, H.; Bewersdorf, J. P.; Harrison, C.; Palandri, F.; Mascarenhas, J.; Palmer, J.; Gerds, A.; Kiladjian, J. J.; Buckley, S.; Derkach, A.; more...
    European Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety
    Review

    Masarova, L.; Mascarenhas, J.; Rampal, R.; Hu, W.; Livingston, R. A.; Pemmaraju, N.
    Cancer (2025)

    Fulltext@MSK | Save
  • AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients
    Journal Article

    Knutson, T. P.; Luo, B.; Kobilka, A.; Lyman, J.; Guo, S.; Munro, S. A.; Li, Y.; Heer, R.; Gaughan, L.; Morris, M. J.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: A retrospective cohort study
    Journal Article

    Lee, Y. H. A.; Hui, J. M. H.; Leung, C. H.; Tsang, C. T. W.; Hui, K.; Tang, P.; Chan, J. S. K.; Dee, E. C.; Ng, K.; McBride, S.; more...
    Prostate Cancer and Prostatic Diseases (2024)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and clinical outcomes in metastatic castration-resistant prostate cancer patients given androgen receptor pathway inhibitors (Alliance A031201)
    Journal Article

    Jensen, J. L.; Bobek, O.; Chan, I. C. C.; Miller, B. C.; Hillman, D. W.; Heller, G.; Druley, T.; Armstrong, A. J.; Morris, M. J.; Milowsky, M. I.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase I and randomized phase II study of ruxolitinib with frontline neoadjuvant therapy in advanced ovarian cancer: An NRG Oncology Group Study
    Journal Article

    Landen, C. N.; Buckanovich, R. J.; Sill, M. W.; Mannel, R. S.; Walker, J. L.; Disilvestro, P. A.; Mathews, C. A.; Mutch, D. G.; Hernandez, M. L.; Martin, L. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Characterization of the use and efficacy of isavuconazonium sulfate in a pediatric oncology and stem cell transplant population: A single institution retrospective review
    Journal Article

    Kunvarjee, B.; Siver, M.; Mathew, S.; Steiger, S.; Lee, Y. J.; Spitzer, B.
    Journal of Pediatric Hematology/Oncology (2024)

    Fulltext@MSK | Save
  • The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
    Journal Article

    Halabi, S.; Guo, S.; Park, J. J.; Nanus, D. M.; George, D. J.; Antonarakis, E. S.; Danila, D. C.; Szmulewitz, R. Z.; McDonnell, D. P.; Norris, J. D.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save